Patient Registries and Trial Readiness in Myotonic Dystrophy – TREAT-NMD/Marigold International Workshop Report
暂无分享,去创建一个
[1] Krzysztof Sobczak,et al. Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA , 2009, Science.
[2] Radim Mazanec,et al. Highly unstable sequence interruptions of the CTG repeat in the myotonic dystrophy gene , 2009, American journal of medical genetics. Part A.
[3] Allan D. Kirk,et al. Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis , 2009, Brain : a journal of neurology.
[4] M. Shriver,et al. Premutation allele pool in myotonic dystrophy type 2 , 2009, Neurology.
[5] Christophe Béroud,et al. 157th ENMC International Workshop: Patient registries for rare, inherited muscular disorders 25–27 January 2008 Naarden, The Netherlands , 2008, Neuromuscular Disorders.
[6] D. Zipes,et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. , 2008, The New England journal of medicine.
[7] M. Cotelli,et al. Cognitive impairment in adult myotonic dystrophies: a longitudinal study , 2007, Neurological Sciences.
[8] C. E. Pearson,et al. Repeat instability: mechanisms of dynamic mutations , 2005, Nature Reviews Genetics.
[9] B. Engelen,et al. 123rd ENMC International Workshop: Management and Therapy in Myotonic Dystrophy, 6–8 February 2004, Naarden, The Netherlands , 2005, Neuromuscular Disorders.
[10] T. Hughes,et al. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. , 2004, The Cochrane database of systematic reviews.